Sort
23,748 grants matching “melanoma”
Cancer cell adaptation to metabolic stress
$1,159,608M. Celeste Simon · University Of Pennsylvania · P01 · FY2015 · CA
Cell Production Facility Core
$1,157,471Mark Dudley · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Cell Prep Core
$1,157,471Steven Rosenberg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,156,887Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
PREDICTING EARLY-STAGE MELANOMA AT HIGH RISK OF RECURRENCE THROUGH MULTIOMICS PROFILING
$1,156,726The University Of Queensland · · FY2025 · Defense Health Agency
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,155,281Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Mutational analysis of signal transducing gene families in malignant melanoma
$1,155,041Yardena Samuels · National Human Genome Research Institute · ZIA · FY2009 · HG
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,153,728Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,153,528Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,153,319Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,151,331Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,151,331Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,151,039Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Family Studies
$1,148,924Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Developing Novel Therapies for High Risk Pediatric Cancers
$1,148,695Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Studies of Human T Regulatory Cells
$1,148,221Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Molecular Analysis Of Human Hereditary Deafness
$1,147,935Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2010 · DC
Molecular Mechanisms of UVA induced apotosis and carcinogenesis
$1,147,898Zigang Dong · University Of Arizona · P01 · FY2008 · CA
General Surgical Pathology
$1,147,052Markku Miettinen · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Genetic and molecular basis for variation in human skin pigmentation
$1,146,930Michael S Marks · Children'S Hosp Of Philadelphia · R01 · FY2020 · AR
SPORE in Skin Cancer
$1,146,135Meenhard Herlyn · Wistar Institute · P50 · FY2009 · CA
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
$1,145,470Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R44 · FY2020 · CA
OVERCOMING IMMUNOTHERAPY RESISTANCE IN ACRAL MELANOMA
$1,144,800University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2025 · Defense Health Agency
OCULAR MELANOMA
$1,144,100Johns Hopkins University · U10 · FY2003 · EY
Animal Model and Genotyping Core Support Facility
$1,143,457Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA